Clinical significance of adenosine receptor agonists

A tétel rövid nézete
dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDepartment of pharmacologyhu_HU
dc.contributor.authorAdigun, Muhammed Oladimeji
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2020-10-15T09:01:04Z
dc.date.available2020-10-15T09:01:04Z
dc.date.created2020-03-06
dc.description.abstractAdenosine is a ubiquitous extracellular signaling molecule with essential functions in human physiology. Adenosine receptors have a widespread expression and extensive effects across different organs. With a noteworthy role in the cardiovascular system, they have been extensively studied for both their therapeutic and diagnostic abilities. 99% of Paroxysmal SVT involving the AV node are successfully terminated with standard doses of adenosine. Adenosine receptor agonist are divided into non-selective, A1, A2 and A3 ARA. The non- selective ARAs are adenosine, NECA and 2-Cl-Ado. The A1 ARA are CAPADENOSON, CCPA, etc. The A2 ARA are APADENOSON, BAY60-6583, BINODENOSON, etc. A3 ARAs are CF-101, CF-102, CF502.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent43hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/296763
dc.language.isoenhu_HU
dc.subjectadenosinehu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleClinical significance of adenosine receptor agonistshu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)